Achieve life sciences to host key opinion leader panel on smoking and e-cigarette cessation

Seattle, wash and vancouver, british columbia, nov. 23, 2021 (globe newswire) -- achieve life sciences, inc. (nasdaq: achv), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced the company will host a key opinion leader (kol) virtual panel event on smoking and e-cigarette cessation on thursday, december 2nd, 2021, at 1:00 pm est.
ACHV Ratings Summary
ACHV Quant Ranking